The reduction in risk is potentially significant. Lowering the amount of cholesterol in the blood by a mere 1 millimole per ...

Millions of people are living with Alzheimer's disease, a progressive, irreversible brain disorder that causes cognitive decline, confusion, memory loss, and many other symptoms. The Alzheimer's Assoc ...

The wandering toolkit has a workbook that helps families come up with a plan in case their loved one wanders away. "Having ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

If someone you love has Alzheimer's disease or another form of dementia — and 7.4 million Americans including 38,300 Utahns do — gift giving can be a bit tricky.

-- At AAIC 2025, the Alzheimer's Association released the first in a series of clinical practice guidelines for the diagnosis, treatment and care of Alzheimer's and all other dementia. -- The ...

Despite encouraging biomarker shifts, oral semaglutide failed to slow cognitive decline in early Alzheimer’s, leading to an ...

Nearly 12 million family members and friends nationwide are serving as dementia caregivers, including more than 500,000 ...

But in people with dementia —which is an umbrella term for mental decline and can be related to a number of diseases such as ...

Alzheimer's disease often begins many years before memory problems appear. During that silent phase, toxic changes slowly ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...

CHICAGO, Nov. 24, 2025 /PRNewswire/ -- The Alzheimer's Association is disappointed that the evoke and evoke+ clinical trials did not demonstrate a statistically significant reduction in Alzheimer's ...